United States

People: Bristol-Myers Squibb Co (BMY)

BMY on New York Consolidated

30 Mar 2017
Change (% chg)

$-0.59 (-1.05%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Glimcher, Laurie 

Dr. Laurie H. Glimcher, M.D., is Independent Director of Bristol-Myers Squibb Company. She has served as the Stephen and Suzanne Weiss Dean of Weill Cornell Medical College and the Cornell University Provost for Medical Affairs since January 2012. In February 2016, Dr. Glimcher was named the next President and Chief Executive Officer of the Dana-Farber Cancer Institute beginning in January 2017. Dr. Glimcher was the Irene Heinz Given Professor of Immunology at the Harvard School of Public Health and Professor of Medicine at Harvard Medical School from 1990 to December 2011. She is a Fellow of the American Academy of Arts and Sciences, a member of the National Academy of Sciences USA, and a member of the Institutes of Medicine of the National Academy of Sciences. She is also a member and past President of the American Association of Immunologists. She was elected to the American Society of Clinical Investigation, the American Association of Physicians and the American Association for the Advancement of Science. Dr. Glimcher serves on the Board of Trustees of Cornell University, the Board of Overseers of Weill Cornell Medical College and the Memorial Sloan-Kettering Cancer Center Board of Overseers. Dr. Glimcher also serves on the Scientific Advisory Boards of Cancer Research Institute, Health Care Ventures, Inc. and American Asthma Foundation.

Basic Compensation

Total Annual Compensation, USD 120,000
Restricted Stock Awards, USD 160,000
Long-Term Incentive Plans, USD --
All Other, USD 20,000
Fiscal Year Total, USD 300,000

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --